Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Sofinnova Crossover I - 14 Feb 2025 SCHEDULE 13D/A Report for Abivax SA Ordinary Shares, par value EUR0.01 per share (ABVX)
- Filing manager
- Sofinnova Crossover I
- Reporting owner
- Sofinnova Crossover I SLP
- Beneficially owned shares
- 7,794,478 shares
- Large-stake signal
-
Ownership
11%Beneficial ownership of this reported class.
Shares
7,794,478 sharesShares beneficially owned as disclosed.
Event date
14 Feb 2025Date tied to the ownership event or amendment.
Accepted by SEC
14 Feb 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 11%
- Symbol
- ABVX
- Shares outstanding
- 70,858,891 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 14 Feb 2025, 16:19:20 UTC
- Event date
- 14 Feb 2025
- Next SEC filing
- 31 Jul 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
Sofinnova Crossover I disclosed 11% ownership in Abivax SA Ordinary Shares, par value EUR0.01 per share (ABVX) on 14 Feb 2025.
Key facts
- Sofinnova Crossover I filed SCHEDULE 13D/A for Abivax SA Ordinary Shares, par value EUR0.01 per share (ABVX).
- Disclosed ownership: 11%.
- Date of event: 14 Feb 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:19.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (7)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sofinnova Crossover I SLP | 11% | 7,794,478 | 7,794,478 | 0 | /s/ Antoine Papiernik | Managing Partner | 0001845105 |
| Sofinnova Partners SAS | 11% | 7,794,478 | 7,794,478 | 0 | /s/ Antoine Papiernik | Managing Partner | 0001574139 |
| Antoine Papiernik | 11% | 7,794,478 | 7,794,478 | 0 | /s/ Antoine Papiernik | Antoine Papiernik | 0001768408 |
| Cedric Moreau | 11% | 7,794,478 | 7,794,478 | 0 | /s/ Cedric Moreau | Cedric Moreau | |
| Kinam Hong | 11% | 7,794,478 | 7,794,478 | 0 | /s/ Kinam Hong | Kinam Hong | |
| Joseph Anderson | 11% | 7,794,478 | 7,794,478 | 0 | /s/ Joseph Anderson | Joseph Anderson | |
| Jacques Theurillat | 11% | 7,794,478 | 7,794,478 | 0 | /s/ Jacques Theurillat | Jacques Theurillat |
CIK / CUSIP context first